Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients

BACKGROUND: Liver cirrhosis is one of the major drivers of hepatocellular carcinoma (HCC). In the present study, we aimed to identify and validate new biomarker for early prediction of HCC development in early-stage cirrhosis patients. METHODS: mRNA expression and clinical parameters of GSE63898, GS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Gang, Li, Yongqiang, Chen, Wenji, Tang, Wenjuan, Shou, Diwen, Luo, Qingling, Chen, Huiting, Zhou, Yongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318773/
https://www.ncbi.nlm.nih.gov/pubmed/34335764
http://dx.doi.org/10.1155/2021/9949492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318773/
https://www.ncbi.nlm.nih.gov/pubmed/34335764
http://dx.doi.org/10.1155/2021/9949492

Ejemplares similares